Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
Date:6/2/2008

Phase 2 Results of Perifosine in the Treatment of Patients with

Relapsed/Refractory Waldenstrom's Macroglobulinemia to be presented

Tomorrow, Tuesday, June 3rd at 12:00pm in Room E450a

NEW YORK, June 2 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that abstracts related to KRX-0401 (Perifosine) have been selected for both poster presentation and publication during the American Society of Clinical Oncology Meeting currently taking place in Chicago, Illinois (May 31 - June 3, 2008).

Copies of these abstracts, which highlight the observed clinical and preclinical activity of KRX-0401 as a single agent and in combination with novel agents are currently available and can be viewed on-line through the ASCO website: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts

The following abstract will be available for viewing during the poster session taking place tomorrow, Tuesday, June 3, 2008, from 8:00am-12:00pm:

Abstract 8546: A Phase 2 trial of the novel oral Akt inhibitor perifosine in relapsed and/or refractory Waldenstrom macroglobulinemia

Investigators: Irene M. Ghobrial, X. Leleu, N. Rubin, R. Leduc, S. Chuma, M. Nelson, P. G. Richardson, S. P. Treon, K. C. Anderson

Following the poster session, lead investigator, Dr. Irene Ghobrial, will be presenting the abstract during the Lymphoma and Plasma Cell Disorders Poster Discussion Forum, scheduled to take place at 12:00pm in Room E450a.

Additionally, the following abstracts have been accepted for publication only:

Abstract 16024: Phase 1 multicenter trial of perifosine in
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
2. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
3. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
4. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
5. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
6. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
7. IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients
8. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
9. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
10. Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer
11. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...YORK, Nov. 25 Reportlinker.com ann...ble in its catalogue: ,, United States Dental ..., http://www.reportlinker.com/p0158733/United-St...to-2015.html ,, United States Dental Devices M...y ,, This report is an essential source for in...
(Date:11/25/2009)...UNSWICK, N.J., Nov. 25 Swissray In... digital Radiography ( ddR ) systems, announced to...ivate Swiss Investor with a long term view towards...uisition included all assets and intellectual prop... years of success and growth Swissray is now poise...
(Date:11/25/2009)... HILL, N.C., Nov. 25 Cempra Pharma...rnandes, president and chief executive officer, wi... Care Conference at 8:50 a.m. EST, December 1, 200... Dr. Fernandes will provide an overview of the com...r the treatment of drug-resistant pathogens includ...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Swissray International Announces New Ownership 2First human gets new antibody aimed at rabies virus 10189 1First human gets new antibody aimed at rabies virus 10189 2First human gets new antibody aimed at rabies virus 10189 3Non AIDS Related Cancers Growing Among HIV Patients 58564 1Non AIDS Related Cancers Growing Among HIV Patients 58564 2Water For People Selected for 241 56 Million Project in Africa 58560 1Water For People Selected for 241 56 Million Project in Africa 58560 2Water For People Selected for 241 56 Million Project in Africa 58560 3Water For People Selected for 241 56 Million Project in Africa 58560 4
...sed life expectancy for people with,Down syndrome,...me, ,Mr. C, is a rarity. A real person whose progr...enty, ,Mr. C, has well surpassed the,average life ...ly in the,late fifties, but in the teens when ,Mr....inical symptoms of Alzheimer,s disease, which is a...
...I -, PRINCETON, N.J. and SAN DIEGO, Aug. 18 Tobi...gy company committed to the,research and product d...g,infectious diseases, today announced the issuanc...d Trademark Office, covering the use of TBR-652, a...for the treatment of HIV-1,infection in adults., ...
Other Medicine Technology:Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 3
(Date:11/26/2009)... of Americans living with diabetes will nearly dou...million in 2034. Over the same period, spending on...lion to $336 billion, even with no increase in the...niversity of Chicago report in the December issue ...iabetes covered by Medicare will rise from 8.2 mil...
(Date:11/26/2009)...n emotional rollercoaster, study finds , ...he fear factor meets the jubilant sports fan. ,...y those who root for the winning team -- enjoy the... match and victory was in doubt, producing feeling...s Thanksgiving weekend as you,re glued to the TV s...
(Date:11/26/2009)... Triangle Dental (RTDental), a leading dental grou...ced the expansion of its services to include LUMIN...millan. , Durham, NC (...nnounce that Dr. Doug Macmillan, an experienced L...l advanced training seminar. RTDental’s abi...
(Date:11/25/2009)... When most people hear t...a chiropractor can also give patients the help the...nt, which is where your jaw (mandible) contacts/co... most common symptoms associated with TMJ dysfunct...the jaw. But many other symptoms can be caused fr...
(Date:11/25/2009)...RNewswire/-SentinelleMedicalInc.,aleadingmanufactu...andCalgaryScientificInc.,aleadingproviderofsoftwar...egis(TM)Breast4DAdvancedVisualizationsoftware. ,...printWebclientbasedmedicalimagingofferinginthemark...zero-footprintaccess-requiringnosoftwaredownload,a...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...exercise may be to blame, experts say , , ...ar crash, American children who are overweight or ... legs and feet that normal-weight children do, a n... the leading cause of death for all kids in the ag...
...stress of the economy,have you pulling your hair o...up for the Holidays? Now is the time to take a br...ry knows people are stretched thin emotionally,phy...re is something for everyone. Spas are upgrading ...
...Inc. (NYSE:, WLP ) today announced the appointmen...t of Application Development. In this role, he wil...f all of WellPoint,s systems. , "A.J. adds a...rd processing industries to our IT leadership team...
...a geneticist has discovered a gene mutation that c...ma. , Catherine Van Raamsdonk, an assistant profe...icine and a team of researchers, have discovered a... Nature , will allow researchers to develop therap...
...s should increase federal funding to allow state h...ate and local public health employees, the preside...said today in a letter to two senators who were ho...merican College of Preventive Medicine (ACPM), and...
...poration is,pleased to announce the launch of Data...iability insurance product. DataBreach(SM) helps b...ce on information technology systems as it,relates...plaguing businesses worldwide in the past few year...
Other Medicine News:Health News:Obese Kids More Prone to Limb Injuries in Car Crashes 2Health News:Obese Kids More Prone to Limb Injuries in Car Crashes 3Health News:WellPoint Announces Appointment of Andrew J. Lang as Senior Vice President of Application Development 2Health News:UBC researchers discover gene mutation that causes eye cancer 2Health News:Increase Public Health Work Force by 100,000 Employees, Public Health Groups Urge Harkin, Coburn 2Health News:Increase Public Health Work Force by 100,000 Employees, Public Health Groups Urge Harkin, Coburn 3Health News:Markel Corporation Announces New DataBreach(SM) Privacy Liability Coverage 2
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: